Ultragenyx Pharmaceutical (RARE) Free Cash Flow (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.46% |
| Dec 31, 2025 | -7.62% |
| Sep 30, 2025 | 16.88% |
| Jun 30, 2025 | 33.21% |
| Mar 31, 2025 | -110.12% |
| Dec 31, 2024 | -8.97% |
| Sep 30, 2024 | 4.76% |
| Jun 30, 2024 | 60.11% |
| Mar 31, 2024 | -273.33% |
| Dec 31, 2023 | 66.71% |
| Sep 30, 2023 | -36.60% |
| Jun 30, 2023 | 31.88% |
| Mar 31, 2023 | -88.92% |
| Dec 31, 2022 | 5.27% |
| Sep 30, 2022 | -22.87% |
| Jun 30, 2022 | 46.95% |
| Mar 31, 2022 | -102.16% |
| Dec 31, 2021 | 12.24% |
| Sep 30, 2021 | 6.11% |
| Jun 30, 2021 | 51.40% |
| Mar 31, 2021 | -108.25% |
| Dec 31, 2020 | -28.37% |
| Sep 30, 2020 | -178.96% |
| Jun 30, 2020 | 176.22% |
| Mar 31, 2020 | -30.77% |
| Dec 31, 2019 | 10.69% |
| Sep 30, 2019 | 0.81% |
| Jun 30, 2019 | 4.58% |
| Mar 31, 2019 | -73.26% |
| Dec 31, 2018 | 18.73% |
| Sep 30, 2018 | 9.38% |
| Jun 30, 2018 | 13.89% |
| Mar 31, 2018 | -11.98% |
| Dec 31, 2017 | -27.45% |
| Sep 30, 2017 | -28.11% |
| Jun 30, 2017 | 20.25% |
| Mar 31, 2017 | -61.05% |
| Dec 31, 2016 | -20.66% |
| Sep 30, 2016 | 28.98% |
| Jun 30, 2016 | 3.61% |
| Mar 31, 2016 | -9.45% |
| Dec 31, 2015 | -30.04% |
| Sep 30, 2015 | -82.33% |
| Jun 30, 2015 | 1.38% |
| Mar 31, 2015 | -64.69% |
| Dec 31, 2014 | 12.22% |
| Sep 30, 2014 | -23.44% |
| Jun 30, 2014 | 9.27% |
| Mar 31, 2014 | -13.01% |
| Dec 31, 2013 | -42.47% |
| Sep 30, 2013 | 16.11% |
| Jun 30, 2013 | -28.05% |